Virus therapy shows promise for tough bile duct cancer in early trial
NCT ID NCT07522476
First seen Apr 14, 2026 · Last updated May 23, 2026 · Updated 7 times
Summary
This study tests a new treatment called VG2025 for people with advanced intrahepatic cholangiocarcinoma, a type of bile duct cancer that has spread. The treatment uses a modified virus to target and attack cancer cells. About 30 adults aged 18 to 75 will receive the therapy to see if it shrinks tumors and how safe it is.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INTRAHEPATIC CHOLANGIOCARCINOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The First Affiliated Hospital，Zhejiang University School of Medicine
Hangzhou, Zhejiang, 310003, China
Conditions
Explore the condition pages connected to this study.